Dalbavancin is a lipoglycopeptide antibiotic indicated for the treatment of acute bacterial skin and skin structure infections in adults, particularly those caused by susceptible Gram-positive organisms… Read more


















































Dalbavancin is a lipoglycopeptide antibiotic indicated for the treatment of acute bacterial skin and skin structure infections in adults, particularly those caused by susceptible Gram-positive organisms such as methicillin-resistant Staphylococcus aureus. This category offers high-quality reference standards for the Dalbavancin API, alongside its pharmacopeial and non-pharmacopeial impurities, including N-nitroso derivatives and deoxy variants. Pharmaceutical laboratories rely on these specialized compounds for comprehensive impurity profiling, method development and rigorous quality control protocols. By utilizing well-characterized reference materials and stable isotope-labelled compounds, analytical chemists can ensure precise quantification and validation of drug products throughout the manufacturing and regulatory submission processes. Whether performing routine analysis or investigating specific degradation pathways, these reference standards provide the necessary support for maintaining compliance and product integrity in antimicrobial research and production.